Citation: Ia. Busmanis et al., ISOLATED PLEURAL EFFUSION WITH HEMATOPOIETIC-CELLS OF MIXED LINEAGE IN A PATIENT RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR AFTER HIGH-DOSE CHEMOTHERAPY, Diagnostic cytopathology, 18(3), 1998, pp. 204-207
Authors:
CLARKE K
BASSER RL
MAHER D
MORGAN DJ
CEBON J
FOX RM
HILL JS
ALT C
BARTLET J
GELDARD H
KAYE AH
GREEN MD
Citation: K. Clarke et al., PHASE-I AND PHARMACOKINETIC STUDY OF KRN8602 ALONE AND WITH FILGRASTIM IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 16(6), 1998, pp. 2181-2187
Authors:
BASSER RL
TO LB
BEGLEY CG
MAHER D
JUTTNER C
CEBON J
MANSFIELD R
OLVER I
DUGGAN G
SZER J
COLLINS J
SCHWARTZ B
MARTY J
MENCHACA D
SHERIDAN WP
FOX RM
GREEN MD
Citation: Rl. Basser et al., RAPID HEMATOPOIETIC RECOVERY AFTER MULTICYCLE HIGH-DOSE CHEMOTHERAPY - ENHANCEMENT OF FILGRASTIM-INDUCED PROGENITOR-CELL MOBILIZATION BY RECOMBINANT HUMAN STEM-CELL FACTOR, Journal of clinical oncology, 16(5), 1998, pp. 1899-1908
Authors:
MORGAN DJ
HILL JS
CLARKE K
STYLLI SS
PARK SJ
CEBON J
BASSER RL
KAYE AH
GELDARD H
MAHER DW
GREEN MD
Citation: Dj. Morgan et al., EFFECT OF FILGRASTIM ON THE PHARMACOKINETICS OF MX2 HYDROCHLORIDE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, Cancer chemotherapy and pharmacology, 41(5), 1998, pp. 423-426
Authors:
THOMAS DM
BASSER RL
SEYMOUR JF
GREEN MD
SZER J
FOX RM
GRIGG AP
Citation: Dm. Thomas et al., PROGRESS IN MANAGEMENT OF ACUTE MYELOID-LEUKEMIA (AML) IN AUSTRALIA SINCE 1980 - A SINGLE INSTITUTION RETROSPECTIVE STUDY, Australian and New Zealand Journal of Medicine, 28(2), 1998, pp. 190-196
Authors:
MORGAN DJ
HILL JS
CLARKE K
STYLLI SS
PARK SJ
CEBON J
BASSER RL
KAYE AH
GELDARD H
MAHER DW
GREEN MD
Citation: Dj. Morgan et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF MX2 HYDROCHLORIDE IN PATIENTS WITH ADVANCED MALIGNANT DISEASE, Cancer chemotherapy and pharmacology, 40(3), 1997, pp. 202-208
Authors:
RASKO JEJ
BASSER RL
BOYD J
MANSFIELD R
OMALLEY CJ
HUSSEIN S
BERNDT MC
CLARKE K
OBYRNE J
SHERIDAN WP
GRIGG AP
BEGLEY CG
Citation: Jej. Rasko et al., MULTILINEAGE MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS IN HUMANS FOLLOWING ADMINISTRATION OF PEG-RHUMGDF, British Journal of Haematology, 97(4), 1997, pp. 871-880
Authors:
BASSER RL
RASKO JEJ
CLARKE K
CEBON J
GREEN MD
GRIGG AP
ZALCBERG J
COHEN B
OBYRNE J
MENCHACA DM
FOX RM
BEGLEY CG
Citation: Rl. Basser et al., RANDOMIZED, BLINDED, PLACEBO-CONTROLLED PHASE-I TRIAL OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR WITH FILGRASTIM AFTER DOSE-INTENSIVE CHEMOTHERAPY IN PATIENTS WITH ADVANCED CANCER, Blood, 89(9), 1997, pp. 3118-3128
Authors:
BASSER RL
RASKO JEJ
CLARKE K
CEBON J
GREEN MD
HUSSEIN S
ALT C
MENCHACA D
TOMITA D
MARTY J
FOX RM
BEGLEY CG
Citation: Rl. Basser et al., THROMBOPOIETIC EFFECTS OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (PEG-RHUMGDF) IN PATIENTS WITH ADVANCED CANCER, Lancet, 348(9037), 1996, pp. 1279-1281
Authors:
OMALLEY CJ
RASKO JEJ
BASSER RL
MCGRATH KM
CEBON J
GRIGG AP
HOPKINS W
COHEN B
OBYRNE J
GREEN MD
FOX RM
BERNDT MC
BEGLEY CG
Citation: Cj. Omalley et al., ADMINISTRATION OF PEGYLATED RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR TO HUMANS STIMULATES THE PRODUCTION OF FUNCTIONALPLATELETS THAT SHOW NO EVIDENCE OF IN-VIVO ACTIVATION, Blood, 88(9), 1996, pp. 3288-3298
Authors:
BASSER RL
TO LB
BEGLEY CG
JUTTNER CA
MAHER DW
SZER J
CEBON J
COLLINS JP
RUSSELL I
OLVER I
GILL PG
FOX RM
SHERIDAN WP
GREEN MD
Citation: Rl. Basser et al., ADJUVANT TREATMENT OF HIGH-RISK BREAST-CANCER USING MULTICYCLE HIGH-DOSE CHEMOTHERAPY AND FILGRASTIM-MOBILIZED PERIPHERAL-BLOOD PROGENITOR CELLS, Clinical cancer research, 1(7), 1995, pp. 715-721
Authors:
CUNNINGHAM D
ZALCBERG JR
RATH U
OLVER I
VANCUTSEM E
SVENSSON C
SEITZ JF
HARPER P
KERR D
PEREZMANGA G
AZAB M
SEYMOUR L
LOWERY K
ACKLAND SP
BASSER RL
CLARKE SJ
GOLDSTEIN D
GREEN MD
GRYGIEL JJ
MCKENDRICK JJ
MILLWARD MJ
OLVER IN
TATTERSALL MHN
THOMSON DB
JAKESZ R
BUSET M
TUENI EA
VANCUTSEM EJD
BAUER J
BESKA F
ADENIS A
BRUNET R
FRANCOIS E
PAILLOT B
ROUGIER P
FINK UFW
KNUTH KRA
KOENIG HJ
BOHME MWJ
WANDER HE
AMADORI D
FRASSINETI L
COCCONI G
PASSALACQUA R
FRIGERIO F
BARNI S
LUPORINI G
LABIANCA R
MARINI G
ZANIBONI A
KLEPP O
TVEIT KM
WIST E
CANDEIAS OFR
GOUVEIA JGP
MARQUES JCN
OLIVEIRA JML
CAVALLI F
DELMORE GD
GOEDHALS L
VOROBIOF DA
ESTEVE AAI
AGUILAR EA
TORRES AA
RUIPEREZ AC
RUBIO ED
SUREDA BM
MANGA GP
ALFONSO PG
GUSTAVSSON B
JEPPSON B
MALMBERG M
STARKHAMMAR H
SVENSSON JH
KEIZER HJ
SCHORNAGEL JH
OBRIEN M
HARPER PG
KERR DJ
SCARFFE JH
TYRELL CJ
Citation: D. Cunningham et al., TOMUDEX (ZD1694) - RESULTS OF A RANDOMIZED TRIAL IN ADVANCED COLORECTAL-CANCER DEMONSTRATE EFFICACY AND REDUCED MUCOSITIS AND LEUKOPENIA, European journal of cancer, 31A(12), 1995, pp. 1945-1954
Citation: Rl. Basser, DOSE-INTENSIVE CHEMOTHERAPY IN BREAST-CANCER - THE NEED FOR APPROPRIATE MEASURES OF OUTCOME, Annals of oncology, 6(7), 1995, pp. 633-635
Citation: Aw. Roberts et al., DO STEADY-STATE PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS PREDICT THE YIELD OF PBPC MOBILIZED BY FILGRASTIM ALONE, Blood, 86(6), 1995, pp. 2451-2451
Authors:
BASSER RL
SOBOL MM
DUGGAN G
CEBON J
ROSENTHAL MA
MIHALY G
GREEN MD
Citation: Rl. Basser et al., COMPARATIVE-STUDY OF THE PHARMACOKINETICS AND TOXICITY OF HIGH-DOSE EPIRUBICIN WITH OR WITHOUT DEXRAZOXANE IN PATIENTS WITH ADVANCED MALIGNANCY, Journal of clinical oncology, 12(8), 1994, pp. 1659-1666
Citation: Rl. Basser et al., CONSERVATIVE MANAGEMENT OF SQUAMOUS-CELL CARCINOMA OF THE ANAL-CANAL, Australian and New Zealand journal of surgery, 64(11), 1994, pp. 754-758